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The major reason for measuring blood lipids is because their el~vation, 
I 
hyperlipoproteinemia, has been associated with increased risk of premature 
I 
heart disease ( 1,2 ,B). Cardiovascular disease is responsible 
' I 
for ·over 5 5% , I 
of all causes of death in the United States. Most disturbing is the: fact that 
' it seems to affect not only men and women over age 65, in whom it ac~ounts for 
over 45% of death, but also the young, particularly the young male ( 11). 
There are a few studies which indicate that coronary atherosclerosis· 
begins early in life. In autopsies of black and white .males and females.be-
tween the.ages of 15 and 19 years, the coronary arteries showed fatty streaks 
in 71% to 83%, and raised atherosclerotic lesions in 7% to 22% (12)., U.S. 
soldiers killed at a mean age of 22 years showed some evidence of coronary 
.vessel atherosclerosis in 77% of the cases in the Korean conflict (3) and 45% . 
of the cases in the Viet Nam.War (s). These findings suggest that detection 
for hyperlipoproteinemia or coronary atherosclerosis should start early in life. 
The lipoproteins are termed alpha (HDL); pre-Beta (VLDL) and Beta (LDL) 
lipoproteins based on these electrophoretic properties. The HDL (high density 
'.lipoproteins), LDL (low density lipoproteins) and VLDL (very lo.w :den~ity lipoproteins) 
designations are related to density gradient centrifugation properties of 
the lipoproteins. 
The different electrophoretogram patterns result from qualitative and 
quant~tative difference in lipoproteins.which are indicative of normal and 
pathological ·conditions ( 5 )·. Normal and abnormal classification j)atterns are 
indicated in Figure 1. 
I 
Although·the pathogenesis of atherosclerosis. is not completely understood . I 
. I 
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Figure 1 : Phenotyping hyperlipoproteinemia C.5). 
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hyperlipoproteinemia. Therapy tolcorrect or control hyperlipoprotei~emia 
/.. I 
might decelerate the rate of deve+opment or atherosclerosis and thus.lessen the 
incidence of co~p;ications such aflischem~b heart disease, myocardial infarction 
' I ' 
I ' ' 
and stroke (g), Therefore early lJentificlation of hyperlipoprotein~ia is 
important . 1 1 
.1,1 f ' 
The specific aiins of this inviestigation were as follows: : 
!! 
I·' I 
L Measurement of the lipi'(). profile of faculty and students at More-
head State University that desire the analysis. 
" ) . 
I . I ! 
2. Inform the participants of the/results of their lipid profile 
. analy~is. ·i l j 
3. Promote awareness of th~ ~ange;s of hyperlipoproteinemia, :parti-
cularly to individuals who are.obese and/or have family histories 
of cardiovas·cular diseases. i : 
I l: 1 
4. Encourage individuals, es~eciafiy high risk persons, to hJve 
a lipid profile.analysis once 4 year. 
I; I I I ' 
5. Compare the lipid profiles ( ch<j>l;esterol, triglycerides, and 
electrophoretograms) of\ :the pa1t~cipants with respect to: 
I' i 
a. age J i 
b. sex # j l 
c. occupation i1 
1 
·: 
e. height-weight reiationship 
;T ' 
f. family history at cardiqvascular diseases 
g. blood pressure .!;, I [ 
·I· I I 
The comparisons of the ·lipid ~fofile~ bf participants with re,sp~ct to their age 
and sex were primary. consideration~f of this study. : 'I . . 
A preliminary investigation i1l~olvingi the ~se 
I ··. 
MENT A) revealed approximately 100 /faculty: members 
of a questionnaire (ATTACH-
' 
. ' 
and 100 students that desired 
. " $ . : 
to participate in this study by donating a: sample of blood. The investigator.is 
I 
l ' 











In addition to the applicant four graduate 
. \I ;, 
Department .of Biological Sciences were 
I;! 
as follows: 
1 •. Mr. Jansen Diener 
2. Mr. Erich Hess 
3. Miss Jan Mccorkle 
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students from the ! 
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determinations, eletrophoresis of[plasma lipoproteins, and 
. I 
" I 




The I blood 
-r~ I , 
samples represented a fasting bloc~ level, 
!1 i /.i 
' This means the participa~ts 
did not ingest any food or drink for ·at 
!¥ 
least 12 hours prior to the vith-
! 
! 
. drawal of the blood sample. j ; i I 
.1, r I 
"''" T:: ::o:u::~·:o:::b:b::~cr: ';:~::::::,~~,:: ~::;~·'·) "" 
was used for .plasma preparation. The oth~r tube was used for serum. 
I I' 
preparation. A hospital certified p~lebob~mist,-Ms. Jan Mccorkle, performed 
the venipunctures and obtained thJ blood k~ples. 
. I 
One portion of the plasma wa~~\stored~I ~vernight (12 hours) at 4° C 
and then observed for clearness anq/or er a.my layer formation. If the plasma· 
' I ' 
'/! h I
was clear .the person very likely d,~d not_ . ~ve any increase in chylomicrons or 
I~ I •! 
VLDL (very high density lipoproteihs). If. 'the plasma was not clear or. had a 
l I · 
F I I ' 
creamy layer it- indicates the person had ndt fasted or that a·lipid clearing 
:i; : I 
I' , I 
problem exists. This data. can be .TI.orrelated with results in the electro-
phoretic portion of the analysis; .,·r .: .· 
The electrophoretic procedure)
1
that was used is basically that of Chin 
I I 
and Blankenhorn (6). Controls wer~ ai:mlyz'ed. 
it 
The electrophoretograms were fu:talyzed with a densitometer at th~ Good 
Samaritan Hospital School ·of Medic-il Technology Laboratory. Therefore I 
. J . 
am very appreciative of the· cooperation 
i 






with the hospital and· Mrs. 
.Serum cholesterol and serum t~iglyce~ide levels were determined spec-








trophotmetrically. 'A Beck.man DB $pectrophotometer with a temperature control 
I 
1 •• 
accessory was . utilized. Controlf and stapdards were used. 
!I ' ' 
The cholesterol analysis was \·1~as.i1cal~y that of Liebermann-Burchrrdt ( 7). 
Blood bilirubin levels can interfere with this analysis and were checked. 
. 1· I ! 
The triglyceride determinatiqn was ei:;sentially that of ·Hantzsch 1 (7). 
'•• I 
··11i I · · 
cf 
There were several q_uestions which w':'re answered by the participants. 
i: i 
An example of the q_uestionnaire fc\"rm used\ is ·noted. as Attachment B. 
:1 ; 
J · I 1 ,/; : I 
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' 
RESULTS AND D~~CU~SION: 
7 
f :. : f 
The screening 'procedure for hYJlElrlfpidemia performed for this epidemiologic . . J' I . I 
study involved volunteer faculty m ,bers and student participants who were found 
· 1·1 I l 
to be generally asymptomatic. As a"'fi:rst step in evaluating the subjeC:t·s for 
I . , 
hyperlipidemia, determinations of fai>ting cliolesterol and triglyceride :concen-
•· : I il · ' · I 
trations showed approximately 40% oi/ th7m tq be hyperlipidemic. · Frede~ickson has 
/, ,,. I 
suggested that I' ' ' . 
j . I 
"hyperlipidemia deserving some at~ention exists when cholepterol : 
concentration exc~eds 220 mg/100 Jjil or;triglyceride concentration !exceeds 
140 mg/100 ml. This rule .is applicabl~'.to all patients under age 1'55.-" (5) 
t ; : ' . . 
'! Combining these criteria with Zelis's .sch.eme (L3) for diagnosis of: hyper-· 
. I I . · ; 
lipidemia (see Figur_e 2), ·55 _of the k37 sub1~cts comprising this· study !were 
found to be measurably hyperlipiO.emi~ 11 deseJvjing some attention." Of ihis 40% 
- 1· l I 
of .hyperlipid~ics, over o_ne fourth :~~~11 inr\ the _'non-oI?timal cholest~rol 'levels 
but acceptable. triglyceride levels; ~;hese aiei the probable Type IIA hyperlipidemics, 
the incidence of which apparently in*reases1-?-th age.· Just under a.foi.irth of the 
. l I I 
hyperlipidemics are probable Type IV{with nonLoptimal cholesterol levels and 
ll ; : 
elevated triglycerides. 
!f ! I · 
Only 2 indir~duals :.had significantly elevated. :cholesterol 
; . . I 
levels along with_ elevate.d triglycer .:a.es; these .are .Probable Type IIB. ; Four young 
. ·1 · . · . I 
people had elevated triglyceride lev1ls with;: optimal cholesterol concentrations. 
It should be mentioned that for the ~lgher a~e groups, ov~r 70% of thoje screened 
q I 
were hyperlipidemic indicating that ~levated cholesterol and triglyceride levels 
j . I . 
are often part of the aging process. '.I '1 · 
It is known that following birttj, there is a very show ascent in ]ipoprotein 
and cholesterol concentrations which lcontin~es. un~il well into the thi~d decade. ( 5) 
During that decade the beta lipopr.otlihs (~L): and _prebeta lipoproteins (VLDL) 
begin to rise at a noticeable rate -4 the iJdividual's physical g~owth jlis ending, 
i . I . 
. he· or she is more sedentary, and an excess df calories easily accumulai!es. Although 
:l r ! 1 
8 
_it is usual for lipid levels to rise with increasing age, as Tables.Band C show, 
this may not be a healthy or even a "normal" trend. (13) 
. In an effort to evaluate the true hyperlipidemic who has a metaboLic disorder 
resulting in one of the five phenotypes, lipoprotein electrophoresis wJs ·performed 
I . . 
' 
to determine '"abnormal lipoprotein levels. The criteria for defining normal cone en-
tration based on percentage of all lipoprotein are those of the International 









These ranges are for fasting plasma in a subject whose physical condit~on and body 
weight are stabilized. 
Upon quantitation of the lipoprotein bands by microdensitometry with the 
lipoprot.eins expressed in relative percentage, 21 participants, about 15% of those 
screened, were found to· have abnormal. lipoprot.ein levels. Table C shows that, of 
the 21 subjects, 7 had high levels of.the alpha lipoprotein (HDL) possibly due to 
exogenous sources of estrogen rather than to any type of metabolic disorder. Of 
any lipoprotein, HDL has the most protein and is closer in weight to albumin than 
' ' the other lipoproteins. It is known that women carry a higher percentage of their 
cholesterol in HDL than men do; This is apparently due to estrogen, for when 
estrogen is given to men, they, too, carry more of their total plasma cholesterol 
in HDL. (4) Because no harmful effects have been noted when HDL levels are in-
creased, those subjects with increased alpha lipoprotein due to estrogen are pre-
eluded from the list of primary hyperlipidemias. 
The most frequently encountered elevated lipoprtoein in th.is study was. the 
l 
beta or LDL, w :ich forms as the result of catabolism of prebeta particles; such 
I 
' 
accumulation indicates a defect in metabolism of beta lipoproteins. This is a 
I . 
Type IIA disorder which is responsible for the high cholesterol level Jn the blood 





cholesterolemia (4). Note that o~· all persons tested, 11 were 




found by the 
lipoprotein electrophoresis to have elevat~d LDL or beta lipoprotein , (see . . Ii : : , . 
Tabll'! C). Three of these, all in \thei7. 20,'s, had optimal plasma cholesterol· 
I: ' ' I 
levels, so that only 8 subjects pro
1
· ved to be Type IV disorders, 3 we~e verified 
.·. i ' l 
as true hyperlipidemics. 
. ' ~ I 
All 3 hall turbid; or lipernic plasma after 24-hour 
''\ I 
refrigerationi two in their fortieii were "heavy" while the teenager was of medium 
j:'; j 
· build. Obesity is often noted wi tH Type IV. · (4) 
Similarly, of the. ·13 ·Probable·.r Type I~ disorders, both proved to be true 
r , 
hyperlipidemics from electrophoretic 'patt~rns even though neither of the 
normal ranges for beta or ~rebeta JaJ exc~eded. ~pe IIB describes a basic 
I ' t ; ' 
defect in LDL catabolism plus· a concdmita~t, often marked, elevation 'of VLDL. . I . . 
To diagnose Type IIB, one must rell ·on eliv~ted levels of cholesterol and 
triglyceride rather.than on relative percentages of beta and prebeta lipoproteins. 
q i : 
;!! I ' 
TaJole D summarizes the comple~e findi~~s of this study. No participants 
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! TOTAL 137 16 11.7 20 14.6 13 9.5 2 1.5 
l ALI, AGES NON,"'.'OPTIMAL PROBABLE PROBABLE PROBABLE 
4 2.9. 55 40. 1 -
' l CHOLESTEROL TYPE IIA TYPE IV TYPE IIJ? '· .:. -. 
' I 
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Cholesterol and Serum Triglyceride levels. 
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Table D summarizes the complete findings of this study. 
I . 
No parti-
cipants had Types I, III, or V, which are kno\'in to be uncommon. 
' 




GROUP N TYPE IIA TYPE IIB %N TYPE IV C/7'-;od 
10-19 18 0 0 0 0 1 I 5.6 I ' 
' ' 
20-29 60 2 3.3 0 0 0 ·o 
30-39 21 2 9.5 0 o. 0 I 0 
40-49 21 2 9.5 1 4.8 2 ' 9.5 
50-59 16 2 -12.5 1 6.3 I 
0 0 
60-69 1 0 0 0 0 I 0 0 
' 
TOTAL 137 I 8 5.8 2 1.5 3 2.2 ALL AGES ' i 
Table D. Incidence of Primary Hy:perlipidemia Confirmed by 
Lipoprotein Electrophoresis and· correlated with Age. 
T 
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Further analysis shows that after the age of 40, the incidence of' hyper-
lipidemia increases· -by a factor of 4. See Table E. , I 
. ' 
AGE GROUP N I I1HIF;ARY HYP~RLIPIDEHICS %N 
Under 40 :-99 ' : ,;; 8 I I 
I ! 
' i8 40 and over 38 ! 21 ' " 




Table E. Inciden<e~ of ~rlipodenia with age 
--·-1.-· 
In attempting to establish a correlation between incidence of hyperlipidemia 
and sex, mixed resu1ts were obtained. A significantly higher incidence of hyp~r-
SAHPLE 1 ' , /TG over 140 mg%i 'IG over 1 40,l/ TG be] ow 140 rngj;, _, · c··o1 ,;; SIZE CVOL '' 0 1 OV"~ !CHOL 210- ovP-ri Il1g/a; .ti 1 · -J. C.. I - ' .,,;., 
SEX N ::>' cf • • -d r , -::.1 ,,.. ....cl.. I ..!.i,..,.-::::il : C/';\f 
~ I __ oO m.'V·> 2 0 _ m •. 10 2o0 n. 0 ,; 2o0 m0 ,o; 0 "9 1.;_.a...,._, , 1V! • 
:\ ~ I 
. Female 
-
78 4· I 34.6 11 :· _9 2 1 
" I' ' 
' Hale 59 5 ! 11 
i I 
9. 0 3 Ii 4?.5 
Table F. Incidence of First ·!Evalu.i ti on Hyperlipidemia Correlated 
\'Ii th Sex. :i ~ ' 
and triglyceride levels. ·See Table F, But by contrast, Table G shows ,that, for 
the confirmed primary hyperlipidemics, .there is a somewhat higher incidence 
' 
' 
among women; this difference' however' is not significant due to the small pop-
ulation size and the consequent low number of hyperlipidemics. 
. Tvne LLB I T"!1ue IV 
Type Elevated Beta "-IIA . Elevated . ' 
SEX N Elevated Beta a:11d Pre beta Pre beta. %N 
' 
Female 78 5 2 2 i 1 .5 - . ' 
' 
Male 59 3 1 0 i 8.5 .. 







No pattern or correlation between hYI,erlipidemia· and unusual or ~ven consis-
' tent blood pressure-readings could be discerned. Nor was a relationsnip seen be-
. tween weight or body build and hyperlipidemia. ·Neither smok~ng nor c~nsumption 
Of alcohol could be correlated with irtcidence of hyperlipidemia in a Jeaningful 
way.· While such· correlations might exist, they were not found in this. small study 
~n whi"ch there were so few verifiable hyperlipidemics. 
The incidence of verified hyperlipidemia found in this study was.lower than 
expected by about half. This is probably due to .the voluntary nature of the par-
' I
ticipation of those screened. Those who participated were aware of the occurrence 
I 
of the disease, generally aware of proper diet, and sought confirmatio'n through 
this study as to their state of good health. Others, who may have· been aware of 
their own high.blood pressure, overweight condition, or high cholesterol levels 
perhaps avoided a potentially dissatisfactory experience. 
Because things can.go wrong with lipid 1Iletabolism as one ages or because of 
genetic disorders, and because so much of what one can do (developing proper 
eating habits, exercising, avoiding the use .of tobac.co) is under voluntary .control, 
everyqne should be screened for lipid abnormalities. This might best be done by 
the family physidan whenever the patient. comes in for a physical 'or insurance 
exam, or for periodic checkups. From the standpoint of preventive medicine, more 
eJ\lphasis should be placed on the problem of hyperlipidemia in younger.people, even 
in children so that low-fat diets may become a habit from an early age. 
If only a single parameter were·to be measured in a screening procedure foe 
hyperlipidemia., it would be the serum cholesterol level. It has been established 
I • 
that the higher the ·serum cholestero:].. .level, the poorer the epidemiolo'gic prognosis. 
' 
(13) This valu.e, when significantly elevated, was. seen 
. i . 
througl::out this study to 
be a first signal for suspecting a susceptible individual to all the 
byperlipidemia. 











cholesterol, triglycerides and other para.~2ters such as the level of systolic 
blood pressure, cig;i.rette-smoking history, postprandial glucose and eie~trocardio-
. I 
graphic evaluation for left ventricular hypertrophy. These factors may oe used to 
quantitate an. individual's r"elative risk and the ~usceptible individu~l can then 
. . . . I 
be treated according to a specific multifactorial approach; i.e., elin!ination 
. ' 
I . 
~f smoking, lowering of blood pressure, and dietary modification designed to achieve 
ideal weight. (13) 
It deserves repetition that, although it is usual for lipid level!s to rise 
with increasing age, this may not be a healthy or even a "normal" trend. It is 
important to note _that 
"many yorkers in the field are now .coming to believe that the ave,rage values 
in the U.S. population are probably higher than should be considered a "normal" 
level. A number of investigators feel that if these normal limit,s were. 
lowered, many more hyperlipidemic persons would be detected _.:. and this is 
the basis for their warning that hyperlipidemia is affecting Americans in 
epicemic proportions." (13) 
Long range studies involving the screening of large random samples of the 
population for frequency and type of lipid disorders with an eye toward inherited 
lipid patterns might provide long overdue data on the lipid problem we're facing 
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A'ITACHMENT A 





Blood levels.of ~holesterol and other lipids are highJ,y significant with 
.respec.t to rrany diseases. Elevated levels of cholesterol nay lead· to atherosclerosis , I 
an:i other cardiovascular problerr$. Once the atherosclerotic process begins. it is 
extremely difficult to corTect the da.mge which has occUITed, but other.danE.ge 
.rray be prevented. Elevated levels of these lipids nay be detrirnental to yot:ng 
ani old people. 
I , 
· I wish to analyze blood samples of ·faculty and students. The analysis will 
iriclude :j,nvestigation of cholesterol and other lipids in the blood. I . 
If you would lil<e to become involved in this experiment by donatirig,·CNE 
SfJfiPLE of-blood please.give the iI1formation requested at the bottom of the page 
a.-rl return it to me as soon as possible. If yqu desire more infornation,please 
call 783-3101 
·:~~-·/~ .. --.. ~-~ ·. . .· . .. 
,. 
Dr. 'David J. Saxon 
UP0 798 Yi.SU 
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' I ,.. 
r .. 
~ • • 1-: 
. '• . 
·, 
~Name l .. D. Number 
. 
• Campus mailing address 
QUESTIONNAIRE FOR LIPID ANALYSIS PARTICIPANT 
Please note that all.information ·will be treated confidentially and 
that 0 i-:i:idividual. results of the· analysis will be .. reported·,. t6 you. 
I 
I 
Sex : Age Occupation I 
(circle one) M 
:.F. 
! - I 
°''Height Weight Race Blood . I·~. 




t.,· What did yCiu. •eat at your ... e.vening meal last night? 
0 
...• .l. 
2. How many· hour-s since,_,_.y.our 
.'3. General diet information: 
last meal ·or .snack?,. ·· · · i. . -.. 
a.) Your usual brea]da'st ,. if any I consi'sts. of 
I 
:0.) Your usual mid-:-day meal .cohsi.sts;,·of :~---------;----~---
c,) Your_ evening meal generally_ consists of·-·~~---------~-
4. Alcoh_ol consumption - estimated: a) :Be-er· - cans/week 
.. "'b) Hard liquor - ___ oz./week 
I 
5, Do you smoke? If so, how many .packs/week? _____ !--. :: 
_, --
·-General· heal th information: :and· family health history.: .. 
Check space if you. L)' have· ever had or 2.) nov,r have any ofr the fol-
lowing. :c Also indic·a te "j,)" to the best-of you~ Lnowledge, if your . 
-·siblings (S )·, . mother (M) I father .(F);;. -grandmott-:>r (GM), or grand-
father (GF) have ever had any of the .. -.following. i · 
Condition: Past Present i Family 
.Heart or coronary problems ' ... . ·. • • • I I I 
High 
., 
blood pressure .............. 
'·Hardening of the arteries~ ....... I 
"Sugar diabetes . . ! .. I I 0· l•,1r·l·'I 1 I I• I I I I I I I I 
Thyroid pr.oblems I •• - •••••• I I I •• I I •• I 
· Removal .of· bvaries-hysterectomy .. ' 
' Li.pid .. disease, ...... , .. o •••••••••• . . . . 
,Kidney disease. t I I I W 9 I I I I I ~ I 0 I I 1 I ' 
.Severe reaction to stress ....... 
'-•Recent ·weight change. (G or L) .... -· 
Hormone treatment. . ................ I 
Chronic infections I .. I .. I I I I I I I • ... ,I : ' • I ·., . ,:, I 
Other I 
Birth control pills.or any other : •. -. ~~.l I 
source of es·trogen_ ..••.••••.•••. .. I i 
6. Describe any other family·health 
helpful or any special diet you are 
form. 
history information whi1ch 
now following on the ba:ck 
I 
may be · 
of this. 
